Navigation Links
Prostate Cancer Treatment Centre Receives Funding for Clinical Trials
Date:11/14/2007

Clinical Trial Aimed to Supplement Current Research Findings on the

Treatment of Localized Prostate Cancer

TORONTO, Nov. 14 /PRNewswire/ -- A Canadian study on High Intensity Focused Ultrasound therapy with the Sonablate(R) 500 - a Health Canada approved treatment for localized prostate cancer - is underway at Can-Am HIFU. Through funding from AstraZeneca Canada Inc, Can-Am HIFU, a prostate cancer treatment centre, will conduct an REB/Health Canada approved clinical trial. The objective of the study is to supplement current research findings on safety and efficacy of HIFU therapy in the treatment of localized prostate cancer. The trial will measure both the biochemical (PSA) cure rates and the Biopsy-proven cure rates at one year.

"AstraZeneca is committed to promoting excellence in Canadian health science research and to supporting the growth of Canada's scientific community," says Marc Zarenda, Scientific Director - Oncology at AstraZeneca Canada Inc. "We are excited to put our support behind this clinical trial."

The nation-wide study will involve a select number of men and will be led by Can-Am HIFU urologists Jack Barkin, MD; Laurence Klotz, MD; Sender Herschorn, MD; Neil Fleshner, MD; Michael Robinette, MD; Antonio Finelli, MD; and Sidney Radomski, MD. The study will play an integral role in building Canadian data on HIFU therapy.

Currently, the data on HIFU are from studies conducted in other countries," said Dr. Barkin, Chief of Staff, Humber River Regional Hospital and Director of Can-Am HIFU. "As more patients are considering HIFU as an alternative treatment option for prostate cancer, we recognize the need to build Canadian data on HIFU therapy."

HIFU has been used in several countries for a number of years to treat men with localized prostate cancer and benign prostatic hyperplasia. The therapy uses ultrasound energy to heat and destroy specifically targeted areas of the prostate. HIFU was approv
'/>"/>

SOURCE USHIFU, LLC
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
2. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
3. Gene Fusion Subtypes in Prostate Carcinoma Have Clinical Implications
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
6. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
7. Study Suggests Soy Protein May Reduce Prostate Cancer Risk
8. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
9. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Nov.25/PRNewswire-USNewswire/--RemediumTechnologie...stopsseverebleeding,wonfirstprizeand$10,000intheMo...Challenge2009,companyofficialsannouncetoday. ,,...Remedium,steampitchedtheirinventionattheGSCSecurit...,, Remedium( www.remediumtechnologies.com )isde...
(Date:11/25/2009)....25/PRNewswire-Asia-FirstCall/--ChinaSkyOne,Medica... CSKI ),a,leadingfullyintegratedpharmaceuticalcomp...hePeople,sRepublicofChina("PRC"),today,announcedth...utefor,theControlofPharmaceuticalandBiologicalProd...sDiagnosticKitforHumanProstateSpecific,Antigen(Col...
(Date:11/25/2009)...,Nov.25/PRNewswire-FirstCall/--Abaxis,Inc.(Nasdaq:...of-carebloodanalysissystems,announcedtodaythatClin...sentatthe21stAnnualPiperJaffrayHealthCareConferenc...ncewillbeheldattheNewYorkPalaceHotelinNewYorkCity....uresandmarketsportablebloodanalysissystemsforusein...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Wellcome Trust funds dengue fever research in Leuven 10516 1Wellcome Trust funds dengue fever research in Leuven 10516 2Oklahoma scientists discover promising new path for treating traumas 60039 1Oklahoma scientists discover promising new path for treating traumas 60039 2CSHL led team discovers rare mutation dramatically increasing schizophrenia risk 10513 1CSHL led team discovers rare mutation dramatically increasing schizophrenia risk 10513 2
...Submission -, TAMPA, Fla., Oct. 25 Sirion Therap...iopharmaceutical company,announced positive prelim...-601) program, which evaluated the steroid,s poten...llowing ocular surgery. "We are very pleased with...al as a potent, well-tolerated steroid treatment f...
...ta presented by Dr. Peter Jones, Director of USC,s...AN FRANCISCO, Oct. 25 SuperGen Inc. (Nasdaq:,SUPG...very, rapid,development and commercialization of t...ancies, today announced as part of a series of,pre...l Conference that,S110, the Company,s decitabine-d...
Other Medicine Technology:Sirion Therapeutics Announces Positive Phase III Results for Difluprednate 2Sirion Therapeutics Announces Positive Phase III Results for Difluprednate 3Sirion Therapeutics Announces Positive Phase III Results for Difluprednate 4SuperGen's Novel Hypomethylating Agent Highlighted at AACR Plenary Session 2SuperGen's Novel Hypomethylating Agent Highlighted at AACR Plenary Session 3
(Date:11/25/2009)...ewswire-USNewswire/--AnarticlebyJanetWoodcock,M.D....rch,titled"ADifficultBalance-PainManagement,DrugSa...ewEnglandJournalofMedicine. ,, (Logo: http://ww..., Inthearticle,WoodcockdiscussesFDAeffortstostrike...editandmanagingtherisksposedbyvariousanalgesics.As...
(Date:11/25/2009)... cancer who were treated with cisplatin-based chem...eurological side effects and Raynaud-like phenomen..., according to a new study published online Novemb...tute . , Marianne Brydy, M.D., of the Department...rgen, Norway, and colleagues conducted a cross-sec...
(Date:11/25/2009)...short to draw definite conclusions, experts say, ...-- In diabetic patients with blocked coronary arte...s at one year whether patients undergo bypass surg...ers report. , Bypass surgery has been the stand...artery disease. However, less invasive approaches ...
(Date:11/25/2009)...ical symptoms, study finds , , WEDNESDA...ffects are among the potential problems faced by l...reated with cisplatin-based chemotherapy, a new st...gian men treated for unilateral testicular cancer ... survey conducted from 1998 to 2002. , The rese...
(Date:11/25/2009)...the4thStraightYear ,, WASHINGTON,Nov.25/PRNew...gia(LCA-GA)issuedthe 4thAnnualReportCardonLungCanc...instthislethaldiseaseinthestateofGeorgia.LCA-GAisa...ganizationdedicatedexclusivelytopatientsupportanda..., (Logo: http://www.newscom.com/cgi-bin/prnh/20...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2
...of NewYork-Presbyterian Hospital and Columbia Univ...wo important new guidelines for treatment of HIV./...International AIDS Society--USA's (IAS-USA) recomm... the Aug. 16 Journal of the American Medical Assoc...
...mber at a Sydney maternity hospital was diagnosed ... families may have to be given antibiotics// as a ...at the women and babies facility of Royal Prince A...l contact with patients and families immediately,'...
... issued an advisory to parents not to give unpaste... including cider, fruit juices and raw milk// to t...ak immune systems are advised not to consume such ...o said that a majority of juice n the country was ...
...ducted in the US, scientists have claimed that a n... way the disease of prostate cancer is diagnosed a...st will be available to patients in 18 months, hav...pread. Researchers had explained that for ma...
...has been issued in Gujarat's flood-ravaged Surat c...us pulmonary syndrome - a disease that spreads thr...adly virus affects the kidneys, lungs, pulmonary s...ibility of contracting the virus is high. Vika...
... launched a 252 million pounds (Rs.21.94 million) ...ld health programme aimed at saving one million li... being provided through the Department for Interna...be spent over five years in support of the second ...
Other Medicine News:Health News:Dr. Scott Hammer Authors Two New Guidelines for HIV Treatment 2Health News:Breakthrough In Prostate Cancer Detection And Treatment 2
Jewelers Forceps
Gill Curved Iris Forceps With Serrations
Gill Curved Iris Forceps
Osher Fixation Forceps
Medicine Products: